Trial Condition(s):
Postmenopause, Pharmacokinetics
Study to evaluate the bioavailability of Estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2)
Bayer Identifier:
91314
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
15
Trial Dates
Phase
1
Could I receive a placebo?
No
Products
Climara (E2 transdermal, BAY86-5435)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
An open-label, randomized, crossover study to evaluate the bioavailability of estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2) in healthy postmenopausal women
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
